Welcome to the 5th Gene Therapy for Neurological Disorders Summit, where groundbreaking advancements in gene therapy for central nervous system (CNS) disorders take center stage. Despite the challenges faced by gene therapy developers in 2022, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have affirmed the transfor
07-09 November 2023